| |
Univariable
|
Multivariable†
|
|---|
|
Crude OR
|
95% CI
|
P value
|
Adjusted OR
|
95% CI
|
P value
|
|---|
|
Age
|
1.06
|
1.01–1.10
|
0.011
|
1.07
|
1.01–1.14
|
0.034
|
|
Gender
|
0.43
|
0.12–1.50
|
0.184
|
0.80
|
0.10–6.06
|
0.826
|
|
SAPS 3
|
1.05
|
1.00–1.10
|
0.033
|
1.05
|
0.98–1.13
|
0.149
|
|
Serum albumin, g/dL
|
0.47
|
0.18–1.26
|
0.133
|
0.58
|
0.13–2.56
|
0.469
|
|
Cytomegalovirus co-infection
|
5.50
|
1.44–20.96
|
0.013
|
3.19
|
0.52–19.63
|
0.212
|
|
Bacterial co-infection
|
3.65
|
0.82–16.19
|
0.089
|
2.90
|
0.34–24.32
|
0.327
|
|
Time to anti-PCP treatment, hour
|
1.00
|
0.99–1.01
|
0.939
|
1.01
|
0.99–1.02
|
0.307
|
|
Failure to initial treatment
|
8.38
|
2.36–29.74
|
0.001
|
14.12
|
2.23–89.38
|
0.005
|
- OR odds ratio, CI confidence interval, SAPS Simplified Acute Physiology Score 3, PCP Pneumocystis pneumonia
